INDEPENDENT NEWS

More cancer drugs confirmed – even more on horizon

Published: Mon 7 Oct 2019 02:05 PM
Hon Dr David Clark
Minister of Health
7 October 2019 PĀNUI PĀPĀHO
MEDIA STATEMENT
Confirmation that PHARMAC will fund two new cancer drugs is further evidence of the good progress the Government is making to improve the treatment of New Zealand’s leading cause of death, Health Minister David Clark says.
From 1 December PHARMAC will fund alectinib (Alecensa) for ALK positive advanced non-small cell lung cancer and trastuzumab emtansine (Kadcyla) for HER-2 positive metastatic breast cancer. A new treatment for multiple sclerosis, ocrelizumab (Ocrevus), is also being funded and access to respiratory disease treatment pirfenidone (Esbriet) is being widened.
“These new drugs will help around 420 people, including people living with advanced cancer,” David Clark said.
‘I’m advised these medicines will be paid for out of the $40 million extra that the Government invested in PHARMAC in the 2019 Budget (over four years). It is great to see that investment making a real difference in people’s lives.
“After years of underfunding by the previous government, we’ve made cancer care and control a major focus.
Key cancer care initiatives include:
Investment in 12 state of the art linear accelerators for radiation treatment – including plans to put machines in Hawke’s Bay, Taranaki and Northland for the first time.
• Release of a Cancer Action Plan and establishment of a Cancer Control Agency to ensure that all New Zealanders have access to the same high quality of care no matter who they are, or where they live.
• $60 million boost to PHARMAC’s funding announced last month to provide even more medicines for more people.
“PHARMAC is currently consulting on three more cancer drugs - olaparib (Lynparza) for ovarian cancer, fulvestrant (Faslodex) for breast cancer and venetoclax (Venclexta) for chronic lymphocytic leukaemia.
“Medicines are critical, but are only one part of cancer care and control. Our plan is comprehensive and covers the full spectrum – from prevention and screening, to radiation treatment and palliative care. We’re also investing in our health workforce – with a record number of doctors and nurses in our DHBs.
“It will take time to modernise our approach to cancer care and control and improve survival rates, but today signifies good progress on the delivery of our plan,” David Clark said.
ends

Next in New Zealand politics

Update on New Zealand and the Cook Islands travel bubble
By: New Zealand Government
Speech: Ardern - Let’s Keep Moving - 2020 Election Campaign Launch
By: New Zealand Labour Party
On Political Twins, And On Labour Extending Its Wage Subsidy Scheme
By: Gordon Campbell
Adjournment Debate: Speaker Trevor Mallard
By: Hansard
Vaping Legislation Passes
By: New Zealand Government
Overall, 82% Trust Pandemic’s Management – Down From 91%
By: Horizon Research Limited
National Releases 2020 Party List
By: New Zealand National Party
How Judith Collins stopped the bleeding
By: Horizon Research Limited
Your Vote 2020: Bringing Election Coverage To Viewers Across TVNZ Channels And Platforms
By: TVNZ
30% Believe Households Worse Off, 298,000 Expect To Lose Jobs
By: Horizon Research Limited
Findings Of Investigation Into COVID-19 Active Cases Privacy Breach
By: State Services Commission
New Zealand suspends extradition treaty with Hong Kong
By: New Zealand Government
New Zealand Must Stand With Free, Democratic Nations
By: ACT New Zealand
Economic Alarm Bells Ring
By: New Zealand National Party
Adjournment Debate: PM Jacinda Ardern
By: Hansard
View as: DESKTOP | MOBILE © Scoop Media